Work

Can We Incorporate Psychosocial Treatment Interventions Into Psychopharmacology Clinical Trials?

Year: 2012

Type: article

Abstract: Article AbstractDr. Schooler believes that the article by Richard Keefe and colleagues in this month's Journal has substantial value to researchers who face an important methodological question in clinical trials of cognitive-enhancing medications in schizophrenia. Do patients in pharmacologic intervention trials need to exercise their cognitive "muscles" for a drug that increases cognitive "muscle mass" to work? This analogy is offered by Keefe et al in their feasibility study of adding cognitive remediation to pharmacologic trials. Dr. Schooler provides an engaging discussion of their study and of the topic in general.

Source: The Journal of Clinical Psychiatry

DOI: 10.4088/jcp.12com07829

Author: Nina R. Schooler

Institutions: State University of New York, SUNY Downstate Health Sciences University

Language: English

Topic: Schizophrenia research and treatment

Subfield: Psychiatry and Mental health

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: bronze

Funders: Eli Lilly and Company, H. Lundbeck A/S